Investment Analysts’ updated eps estimates for Tuesday, January 7th:
Apple (NASDAQ:AAPL) had its sell rating reaffirmed by analysts at Moffett Nathanson. The firm currently has a $188.00 price target on the stock, down from their previous price target of $202.00.
Albertsons Companies (NYSE:ACI) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $22.00 target price on the stock.
American Resources (NASDAQ:AREC) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $4.00 price target on the stock.
Avation (LON:AVAP) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 285 ($3.57) target price on the stock.
Bloomin’ Brands (NASDAQ:BLMN) had its equal weight rating reiterated by analysts at Barclays PLC. The firm currently has a $13.00 price target on the stock, down from their previous price target of $19.00.
Bridge Investment Group (NYSE:BRDG) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $10.00 price target on the stock, down from their previous price target of $12.00.
BioXcel Therapeutics (NASDAQ:BTAI) had its underperform rating reissued by analysts at Bank of America Co.. They currently have a $0.25 target price on the stock, down from their previous target price of $7.00.
Close Brothers Group (LON:CBG) had its buy rating reiterated by analysts at Shore Capital.
Cboe Global Markets (NASDAQ:CBOE) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $174.00 target price on the stock, down from their previous target price of $203.00.
Cipher Mining (NASDAQ:CIFR) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $11.00 price target on the stock.
Canadian National Railway (TSE:CNR) (NYSE:CNI) had its outperform rating reaffirmed by analysts at JPMorgan Chase & Co..
Corero Network Security (LON:CNS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 24 ($0.30) price target on the stock.
CytomX Therapeutics (NASDAQ:CTMX) had its neutral rating reissued by analysts at HC Wainwright.
Citius Pharmaceuticals (NASDAQ:CTXR) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $9.00 target price on the stock.
Carvana (NYSE:CVNA) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $330.00 target price on the stock.
Diageo (LON:DGE) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a GBX 2,500 ($31.28) price target on the stock.
Dine Brands Global (NYSE:DIN) had its equal weight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $32.00 price target on the stock, down from their previous price target of $43.00.
Dine Brands Global (NYSE:DIN) had its neutral rating reissued by analysts at UBS Group AG. They currently have a $32.00 price target on the stock, down from their previous price target of $44.00.
DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $44.00 price target on the stock.
DocuSign (NASDAQ:DOCU) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $124.00 target price on the stock.
ENI (NYSE:E) had its equal weight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $31.60 price target on the stock, down from their previous price target of $37.50.
Excelerate Energy (NYSE:EE) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a $31.00 target price on the stock, up from their previous target price of $22.00.
Federated Hermes (NYSE:FHI) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $42.00 price target on the stock, down from their previous price target of $49.00.
Forge Global (NYSE:FRGE) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co..
FuboTV (NYSE:FUBO) had its neutral rating reissued by analysts at Roth Mkm. Roth Mkm currently has a $4.75 target price on the stock, up from their previous target price of $2.00.
Forward Air (NASDAQ:FWRD) had its hold rating reaffirmed by analysts at Benchmark Co..
GSK (LON:GSK) had its underweight rating reiterated by analysts at JPMorgan Chase & Co..
GitLab (NASDAQ:GTLB) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $85.00 target price on the stock.
Hill & Smith (LON:HILS) had its hold rating reiterated by analysts at Shore Capital.
Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $5.00 price target on the stock.
Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $41.00 target price on the stock.
Hut 8 (NASDAQ:HUT) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $35.00 price target on the stock.
Intercontinental Exchange (NYSE:ICE) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $200.00 target price on the stock.
3i Group (LON:III) had its top pick rating reaffirmed by analysts at JPMorgan Chase & Co..
Immuneering (NASDAQ:IMRX) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $15.00 price target on the stock.
Immunic (NASDAQ:IMUX) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $17.00 target price on the stock.
Inchcape (LON:INCH) had its buy rating reaffirmed by analysts at Citigroup Inc..
Kraft Heinz (NASDAQ:KHC) had its in-line rating reissued by analysts at Evercore ISI. The firm currently has a $35.00 target price on the stock, down from their previous target price of $38.00.
Kainos Group (LON:KNOS) had its buy rating reissued by analysts at Shore Capital.
Kilroy Realty (NYSE:KRC) had its neutral rating reissued by analysts at Mizuho. They currently have a $43.00 price target on the stock, down from their previous price target of $45.00.
Quaker Chemical (NYSE:KWR) had its neutral rating reissued by analysts at Piper Sandler. The firm currently has a $170.00 price target on the stock, down from their previous price target of $200.00.
Lucid Group (NASDAQ:LCID) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $3.00 target price on the stock.
LyondellBasell Industries (NYSE:LYB) had its neutral rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $95.00 price target on the stock, down from their previous price target of $112.00.
Mondelez International (NASDAQ:MDLZ) had its equal weight rating reiterated by analysts at Wells Fargo & Company. They currently have a $61.00 price target on the stock, down from their previous price target of $74.00.
Melrose Industries (LON:MRO) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a GBX 850 ($10.63) price target on the stock.
Inari Medical (NASDAQ:NARI) had its market perform rating reiterated by analysts at William Blair.
Inari Medical (NASDAQ:NARI) had its hold rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $80.00 price target on the stock, up from their previous price target of $74.00.
Inari Medical (NASDAQ:NARI) had its neutral rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $80.00 price target on the stock, down from their previous price target of $81.00.
Nuvation Bio (NYSE:NUVB) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $10.00 price target on the stock, up from their previous price target of $6.00.
NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $190.00 target price on the stock.
NEXT (LON:NXT) had its hold rating reaffirmed by analysts at Shore Capital.
Oculis (NASDAQ:OCS) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $28.00 price target on the stock.
Old Dominion Freight Line (NASDAQ:ODFL) had its neutral rating reaffirmed by analysts at Susquehanna. Susquehanna currently has a $195.00 price target on the stock, down from their previous price target of $218.00.
Outset Medical (NASDAQ:OM) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $3.00 price target on the stock.
Playa Hotels & Resorts (NASDAQ:PLYA) had its hold rating reaffirmed by analysts at Truist Financial Co.. Truist Financial Co. currently has a $13.00 target price on the stock.
Ready Capital (NYSE:RC) had its neutral rating reiterated by analysts at B. Riley. They currently have a $10.00 target price on the stock, down from their previous target price of $12.00.
Relx (LON:REL) had its overweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a GBX 4,550 ($56.92) price target on the stock.
Raymond James (NYSE:RJF) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $166.00 target price on the stock, up from their previous target price of $151.00.
RingCentral (NYSE:RNG) had its underweight rating reiterated by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $30.00 price target on the stock, down from their previous price target of $38.00.
Roku (NASDAQ:ROKU) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $100.00 price target on the stock.
Ross Stores (NASDAQ:ROST) had its market perform rating reaffirmed by analysts at Sanford C. Bernstein. They currently have a $165.00 price target on the stock, down from their previous price target of $178.00.
Sabre (NASDAQ:SABR) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $4.00 target price on the stock, down from their previous target price of $5.00.
Saia (NASDAQ:SAIA) had its neutral rating reissued by analysts at Susquehanna. They currently have a $530.00 price target on the stock, down from their previous price target of $565.00.
The Sage Group (LON:SGE) had its buy rating reaffirmed by analysts at Citigroup Inc..
TD SYNNEX (NYSE:SNX) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $140.00 target price on the stock.
STAAR Surgical (NASDAQ:STAA) had its hold rating reissued by analysts at Needham & Company LLC.
Constellation Brands (NYSE:STZ) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $308.00 target price on the stock.
Suncor Energy (NYSE:SU) (TSE:SU) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $66.00 price target on the stock.
Stryker (NYSE:SYK) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $425.00 target price on the stock.
Stryker (NYSE:SYK) had its market perform rating reiterated by analysts at JMP Securities.
Stryker (NYSE:SYK) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $442.00 price target on the stock.
TotalEnergies (NYSE:TTE) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $64.10 price target on the stock, down from their previous price target of $70.40.
Tyler Technologies (NYSE:TYL) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $615.00 target price on the stock, down from their previous target price of $670.00.
Ulta Beauty (NASDAQ:ULTA) had its outperform rating reiterated by analysts at Telsey Advisory Group. They currently have a $500.00 target price on the stock.
Unum Group (NYSE:UNM) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $79.00 price target on the stock, up from their previous price target of $74.00.
Victory Capital (NASDAQ:VCTR) had its neutral rating reaffirmed by analysts at B. Riley. B. Riley currently has a $60.00 price target on the stock, up from their previous price target of $57.00.
Viridian Therapeutics (NASDAQ:VRDN) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $38.00 price target on the stock.
Verisk Analytics (NASDAQ:VRSK) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $300.00 price target on the stock.
XOMA (NASDAQ:XOMA) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $123.00 price target on the stock.
DENTSPLY SIRONA (NASDAQ:XRAY) had its in-line rating reissued by analysts at Evercore ISI. The firm currently has a $20.00 price target on the stock.
ZoomInfo Technologies (NASDAQ:ZI) had its equal weight rating reissued by analysts at Wells Fargo & Company. They currently have a $11.00 target price on the stock, down from their previous target price of $14.00.
Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.
